EditorialKommentar
Azithromycin for Cesarean Delivery—From Trial to Practice
JAMA · 03.11.2026 · 336 (17) · 1511
DOI: 10.1001/jama.2026.16532 ↗Kurz gefasst
Editorial in der Zeitschrift JAMA, erschienen am 03.11.2026. Verfasst von Alan T N Tita und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Women's Reproductive Health, Department of Obstetrics and Gynecology, and Mary Heersink Institute for Global Health, University of Alabama…. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Center for Women's Reproductive Health, Department of Obstetrics and Gynecology, and Mary Heersink Institute for Global Health, University of Alabama at Birmingham.
- Department of Biostatistics, University of Alabama at Birmingham.
- Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill.
Zitieren
APA
Tita, A. T. N., Szychowski, J. M., & Boggess, K. (2026). Azithromycin for Cesarean Delivery—From Trial to Practice. JAMA, 336(17), 1511. https://doi.org/10.1001/jama.2026.16532
Vancouver
Tita ATN, Szychowski JM, Boggess K. Azithromycin for Cesarean Delivery—From Trial to Practice. JAMA. 2026;336(17):1511. doi:10.1001/jama.2026.16532
BibTeX
@article{Tita2026,
author = {Tita, Alan T N and Szychowski, Jeff M and Boggess, Kim},
title = {Azithromycin for Cesarean Delivery—From Trial to Practice},
journal = {JAMA},
year = {2026},
volume = {336},
number = {17},
pages = {1511},
doi = {10.1001/jama.2026.16532}
}
EUVIMED